谷–丙转氨酶活性测定方法的改进
The Improvement of the Existing Experimental Scheme for the Determination of Serum ALT Activity
DOI: 10.12677/HJBM.2021.113019, PDF, 下载: 339  浏览: 1,470  国家自然科学基金支持
作者: 邓文溢, 荣欣茹:首都医科大学第四临床医学院,北京;文江平*:首都医科大学附属北京同仁医院检验科,北京
关键词: 血清谷丙转氨酶酶活性测定改进Serum ALT Determination of ALT Activity Improvement
摘要: 背景:目前,谷–丙转氨酶活性采用比色法测定。但在经典测定方案中,加入显色剂后,对照管中须加入与测量组等体积的谷丙转氨酶底物液,而对照管中先前加入的血清未灭活,可能具有酶活性,并与底物液发生额外的转氨基反应,造成阴性对照失真。目的:探究和了解经典谷–丙转氨酶活性测定实验方案的原理和流程,优化原有实验方案。方法:按经典方案进行操作,发现其由于对照管转氨酶不及时灭活可能对照失真的问题;改进方案验证,将测定管和对照管分别细分为灭活管与非灭活管,按经典方案进行操作,并对实验结果进行比较分析。结果:灭活与否显著影响对照管的光密度值,但不影响测定管光密度值。即灭活后的对照管光密度值明显小于未灭活的对照管,而灭活的测定管光密度值则几乎与未灭活的测定管相等。结论:经典实验在颜色反应前未对已有的转氨酶灭活,导致转氨基反应持续进行,对照管无法形成阴性对照。应该将原实验所有试管在颜色反应之前统一进行高温处理,以此将血清中的转氨酶及时灭活。
Abstract: Background: At present, colorimetry was used to determine the activity of serum ALT. However, in this classical measurement scheme, we should add the same volume of ALT substrate solution to the control group as the experimental group after we add chromogenic agent. The serum ALT added before has not been inactivated, which means it may still have enzyme activity and catalyze addi-tional transamination with substrate solution at the same time, resulting in the distortion of the negative control. Objective: To explore and understand the principle and process of the classical experiment for the determination of ALT activity and optimize the original experimental scheme. Methods: We operated the classical scheme, and found that the inactivation of transaminase in the control tubes in time might cause the distortion of negative control. The improved scheme was set up to verify this conjecture, where the test tubes in the experimental group and the control group were both divided into inactivated tubes and non-inactivated tubes respectively. We operated the improved scheme in accordance with steps of the classical scheme and compared the results be-tween the two schemes. Results: The inactivation has a significant effect on the optical density of the control tubes, but not on that of the experiment tubes. That is, the optical density of the inactivated control tubes was significantly lower than that of the uninactivated control tubes in the original scheme, and the optical density of the inactivated experimental tubes was almost the same as that of the uninactivated experimental tubes in the original scheme. Conclusion: The classical experi-ment did not inactivate the existing ALT before the color reaction, which led to the continuous transamination so that the negative control could not be formed between the control group and ex-perimental group. All test tubes in the original experiment should be uniformly processed at high temperature before the color reaction so as to inactivate the serum ALT in time.
文章引用:邓文溢, 荣欣茹, 文江平. 谷–丙转氨酶活性测定方法的改进[J]. 生物医学, 2021, 11(3): 142-148. https://doi.org/10.12677/HJBM.2021.113019

参考文献

[1] 侯燕芝, 张海燕. 肝脏疾病与血清酶活性的分析测定:血清谷-丙转氨酶活性测定[M]. 医学生物学实验教程. 北京: 北京大学医学出版社.
[2] 赵崇贵, 罗菊香. 血清总胆汁酸及谷丙转氨酶测定在肝胆疾病中的意义[J]. 吉林医学, 2010, 31(24): 4042.
[3] 陈洁, 吴建锋. 血清酶与总胆汁酸联合检测在常见肝脏疾病中的诊断价值[J]. 实用医技杂志, 2011, 13(1): 35-36.
[4] 刘素霞. 肝功能检查对诊断慢性乙型肝炎的临床意义[J]. 中囯校医, 2015, 29(12): 938, 941.
[5] 吕晓. 6项肝功能指标检测在诊断肝病方面的临床价值分析[J]. 当代医药论丛, 2014, 12(8): 42-43.
[6] 胡司淦, 邵杉, 吴士礼, 刘进军, 宣玲, 李妙男, 等. 肝功能异常水平对慢性心力衰竭患者的预测价值[J]. 岭南心血管病杂志, 2013, 19(2): 178-181.
[7] 袁艳伟. 肝炎肝硬化患者的肝功能检验结果的临床意义分析[J]. 大家健康(下旬版), 2015(5): 79.
[8] 黄斌伦, 叶均, 严春霞, 金耀建, 高素华, 金苑青, 朱莞玲. 某高校新生谷丙转氨酶升高原因的调查分析[J]. 金华职业技术学院学报, 2016, 16(6): 79-82.
[9] 刘瑜. 慢性乙肝合并肝硬化患者血清谷丙转氨酶、乙肝表面抗原水平与肝功能的相关性分析[J]. 中外女性健康研究, 2018(11): 138, 155.
[10] 董入奈. 肝损伤与谷丙转氨酶的动态关系(附44例临床分析) [J]. 综合临床医学, 1995(4): 39-40.
[11] Kim, H.C., Nam, C.M., Jee, S.H., Han, K.H., Oh, D.K. and Suh, I. (2004) Normal Serum Aminotransferase Concentration and Risk of Mortality from Liver Diseases: Prospective Cohort Study. BMJ, 328, Article No. 983.
https://doi.org/10.1136/bmj.38050.593634.63
[12] Kariv, R., Leshno, M., Beth-Or, A., Strul, H., Blendis, L., Kokia, E., Noff, D., Zelber-Sagie, S., Sheinberg, B., Oren, R. and Halpern, Z. (2006) Reevaluation of Serum Alanine Aminotransferase Upper Normal Limit and Its Modulating Factors in a Large-Scale Population Study. Liver International, 26, 445-450.
https://doi.org/10.1111/j.1478-3231.2006.01197.x
[13] Van der Poorten, D., Kenny, D.T., Butler, T. and George, J. (2007) Liver Disease in Adolescents: A Cohort Study of High-Risk Individuals. Hepatology, 46, 1750-1758.
https://doi.org/10.1002/hep.21918
[14] Lee, J.K., Shim, J.H., Lee, H.C., Lee, S.H., Kim, K.M., Lim, Y.S., Chung, Y.H., Lee, Y.S. and Suh, D.J. (2010) Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations with Normal Liver Histology. Hepatology, 51, 1577-1583.
https://doi.org/10.1002/hep.23505
[15] 董忠生, 杨少龙, 傅宜方. 从单项筛检ALT结果看常见肝病的“过度诊断”与“过度治疗” [J]. 医学争鸣, 2014, 5(2): 20-24.
[16] 黄佰里, 朱立春, 王拥军, 徐霄勤, 严力行. 献血者筛查ALT作用的探讨[J]. 中国输血杂志, 2002, 15(2): 123-124.
[17] 何博, 黄晓斌, 戚艳萍, 苏玮, 陈小光. 广州血液中心无偿献血者初筛ALT活性效果评价[J]. 中国输血杂志, 2017, 30(7): 796-798.
[18] 杨茹, 李刚, 姚立. 武汉地区献血人群转氨酶异常升高原因探讨[J]. 中国输血杂志, 2016, 29(6): 635-637.
[19] 陈善华, 王志红. 献血员筛查丙氨酸氨基转移酶的重要性分析及评价[J]. 临床血液学杂志(输血与检验版), 2012, 25(5): 674, 684.